| 838 | 21 | 209 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨万古霉素不良反应发生的一般规律和特点,为临床合理用药提供参考。方法:检索1986–2019年中国知网、万方、维普数据库关于万古霉素不良反应的文献报道,按照患者一般情况、用药情况、不良反应发生及转归等进行统计分析。结果:共收集161篇文献,包含190例万古霉素所致的不良反应,男性多于女性,中年组发生率最高,发生时间在2~10 d的占53.16%(101/190),共累及7个系统,以皮肤及其附件(40.53%)、全身系统(18.26%)、泌尿系统(14.48%)为主。本研究显示全身性损害的危险因素可能与患者性别、年龄、过敏史、合并用药以及用法用量等因素无关。结论:万古霉素不良反应表现多样,建议临床应予以重视,合理用药,确保患者用药安全有效。
Abstract:Objective: To explore the general regularities and characteristics of vancomycin-induced adverse drug reaction(ADR), and provide references for rational drug use in clinic. Methods: Vancomycin-induced ADRs from 1986 to 2019 were searched in CNKI, Wanfang, VIP databases and statistically analyzed in terms of general information of patients, medication information, occurrence and prognosis of ADRs, etc. Results: A total of 161 literature, 190 cases of vancomycin-induced ADRs were enrolled in this study, among which males were more than females. Most ADRs occurred in middle aged patients. 53.16%(101/190) of ADRs occurred from 2 to 10 days after administration. And 7 systems were involved in ADRs associated with vancomycin, among which the main diseases were skin and its accessories(40.53%), systemic system(18.26%) and urinary system(14.48%). This study showed that the risk factors of systemic damage in patients might not be related to gender, age, allergic history, combined medications, usage and dosage. Conclusion: Vancomycin-induced ADRs were varied. More attentions should be paid to ADRs caused by vancomycin in clinic in order to improve the rational use of drugs and ensure safe and effective medication for patients.
[1]陈佰义,管向东,何礼贤,等.万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561-573.
[2]赵春丽,裴航,赵保红,等.95例万古霉素不良反应文献分析[J].中国药物警戒,2018,15(6):354-358.
[3]刘晓翠,王超,张弋.替考拉宁所致全身性损害不良反应文献分析[J].中国医院药学杂志,2019,39(22):2319-2323.
[4]陶娌娜,曲晓宇,张四喜,等.我院2013-2014年720例使用万古霉素患者临床用药分析[J].中国药房,2017,28(12):1647-1651.
[5]何娜,苏珊,翟所迪,等.《中国万古霉素治疗药物监测指南(2020更新版)》解读[J].临床药物治疗杂志,2021,19(1):12-16.
[6]王东晓,朱曼,郭代红,等.930例糖肽类和唑烷酮类抗感染药物药品不良反应/事件报告分析[J].中国药物应用与监测,2017,14(1):37-41.
[7]陈叶红,张林.288例万古霉素不良反应分析[J].中国乡村医药,2019,26(10):42-44.
[8]黎素梅.注射药物配伍后不溶性微粒检查的重要性[J].淮海医药,2002,20(2):176-177.
基本信息:
中图分类号:R978.1
引用信息:
[1]孙宝,白延宁,张媛媛,等.190例万古霉素不良反应的文献分析[J].中国药物应用与监测,2021,18(02):106-109.
基金信息:
国家自然科学基金项目(81573549)
2021-04-25
2021-04-25